Empery Asset Management, LP - Q1 2022 holdings

$21.3 Million is the total value of Empery Asset Management, LP's 77 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was - .

 Value Shares↓ Weighting
NewTC BIOPHARM HOLDINGS PLC*w exp 02/08/202$1,384,0002,823,528
+100.0%
6.50%
NewBRC INC*w exp 02/09/202$1,203,000269,212
+100.0%
5.65%
NewSUNSHINE BIOPHARMA INC$1,104,000450,450
+100.0%
5.19%
NewTHE VALENS COMPANY INC$688,000400,000
+100.0%
3.23%
REED NewREEDS INC$421,0001,400,000
+100.0%
1.98%
NewCEA INDUSTRIES INC*w exp 02/11/202$335,000500,000
+100.0%
1.57%
SLNO NewSOLENO THERAPETUCS INC$313,0001,401,400
+100.0%
1.47%
CALA NewCALITHERA BIOSCIENCES INC$313,000775,925
+100.0%
1.47%
NewSUNSHINE BIOPHARMA INC*w exp 02/15/202$233,000235,200
+100.0%
1.10%
NewDIRECT DIGITAL HOLDINGS INC*w exp 02/15/202$194,000270,000
+100.0%
0.91%
AGTC NewAPPLIED GENETIC TECHNOLOGIES$107,000100,000
+100.0%
0.50%
NewSTATERA BIOPHARMA INC$105,000333,016
+100.0%
0.49%
NewMARIS TECH LTD*w exp 02/04/202$88,000297,600
+100.0%
0.41%
NewIMPERIAL PETE INC$83,00057,500
+100.0%
0.39%
NewGREENLIGHT BIOSCIENCES HLDS P*w exp 02/02/202$72,00093,837
+100.0%
0.34%
NewFGI INDUSTRIES LTD*w exp 01/21/202$68,000102,500
+100.0%
0.32%
ADRAWS NewADARA ACQUISITION CORP*w exp 02/11/202$64,000199,999
+100.0%
0.30%
INM NewINMED PHARMACEUTICALS INC$58,00061,741
+100.0%
0.27%
NewMOUNT RAINIER ACQUISITION CORP*w exp 11/27/202$48,000190,764
+100.0%
0.23%
NLSPW NewNLS PHARMACEUTICALS AG*w exp 09/25/202$38,000150,000
+100.0%
0.18%
PXSAW NewPYXIS TANKERS INC*w exp 09/15/202$34,000160,000
+100.0%
0.16%
NewREVELATION BIOSCIENCES INC*w exp 01/10/202$30,000233,382
+100.0%
0.14%
NewQUALTEK SERVICES INC*w exp 02/14/202$24,00041,773
+100.0%
0.11%
NewAMERICAN REBEL HOLDINGS INC*w exp 01/20/202$21,00060,240
+100.0%
0.10%
LIXTW NewLIXTE BIOTECHNOLOGY HLDGS IN*w exp 01/01/202$20,000105,263
+100.0%
0.09%
NewCACTUS ACQUISITION CORP I LTD*w exp 08/17/202$17,000100,000
+100.0%
0.08%
NRACW NewNOBLE ROCK ACQUISITION CORP*w exp 01/31/202$4,00015,961
+100.0%
0.02%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
POLISHED COM INC4Q3 202224.1%
FAT BRANDS INC4Q3 20228.6%
SURROZEN INC4Q3 20227.8%
HARBOR CUSTOM DEVELOPMENT INC4Q3 20226.0%
HAGERTY INC4Q3 20223.0%
NUTRIBAND INC4Q3 20222.7%
LIGHTNING EMOTORS INC4Q3 20223.1%
SURGEPAYS INC4Q3 20222.2%
PEPPERLIME HEALTH ACQUSTN CO4Q3 20221.4%
ARBE ROBOTICS LTD4Q3 20220.9%

View Empery Asset Management, LP's complete holdings history.

Latest significant ownerships (13-D/G)
Empery Asset Management, LP Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
RedHill Biopharma Ltd.January 13, 20235,906,1246.1%
Volcon, Inc.January 13, 20239,057,97110.0%
Direct Digital Holdings, Inc.January 12, 2023270,0005.0%
iSpecimen Inc.January 12, 2023437,5004.7%
Kiromic Biopharma, Inc.January 12, 2023491,55410.0%
Permex Petroleum CorpJanuary 12, 2023185,1919.6%
1847 Goedeker Inc.January 24, 20228,449,2555.0%
Bit Brother LtdJanuary 24, 20223,900,0005.0%
KIORA PHARMACEUTICALS INCJanuary 24, 2022534,3114.0%
TITAN PHARMACEUTICALS INCJanuary 24, 2022860,4485.0%

View Empery Asset Management, LP's complete significant-ownership history.

Latest filings
TypeFiled
32024-02-28
42024-02-28
SC 13G/A2024-01-23
SC 13G/A2024-01-11
SC 13G2024-01-11
SC 13G2024-01-10
SC 13G2024-01-09
SC 13G2024-01-09
SC 13G2024-01-09
SC 13G2024-01-09

View Empery Asset Management, LP's complete filings history.

Compare quarters

Export Empery Asset Management, LP's holdings